Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bal Pharma has informed that it submitted the details of businesses transacted at the 34rd Annual General Meeting of the Company conducted through audio visual means, on 24.09.2021. Shailesh Siroya was elected as Chairman and he chaired the proceedings of the meeting with requisite quorum. Ordinary and special businesses are enclosed.
The above information is a part of company’s filings submitted to BSE.
